Heron Therapeutics, Inc.
NASDAQ:HRTX
Overview | Financials
Company Name | Heron Therapeutics, Inc. |
Symbol | HRTX |
Currency | USD |
Price | 1.58 |
Market Cap | 240,310,100 |
Dividend Yield | 0% |
52-week-range | 1.04 - 3.93 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Craig Alexander Collard |
Website | https://www.herontx.com |
An error occurred while fetching data.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD